Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,466.50
-0.50 (-0.03%)
Jul 30, 2025, 11:56 AM CET
Genmab Market Cap
Genmab has a market cap or net worth of 90.22 billion as of July 30, 2025. Its market cap has decreased by -20.93% in one year.
Market Cap
90.22B
Enterprise Value
68.95B
Revenue
22.30B
Ranking
n/a
PE Ratio
11.58
Stock Price
1,466.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 90.22B, an increase of 2,348.95%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 90.22B | -4.84% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | 161.11B | 67.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,006.90B |
| Coloplast | 139.24B |
| Demant | 59.60B |
| ALK-Abelló | 43.68B |
| H. Lundbeck | 33.89B |
| Ambu A/S | 27.04B |
| Zealand Pharma | 26.60B |
| Bavarian Nordic | 18.14B |